Company Information
CIN
Status
Date of Incorporation
28 April 2010
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
18,200,000
Authorised Capital
40,000,000
Directors
Shailaja Bommanpad Manohar
Director/Designated Partner
over 2 years ago
over 2 years ago
Manohar Vishwanatham Bommanpad
Director/Designated Partner
over 9 years ago
over 9 years ago
Satish Ramshankar Varma
Director
over 15 years ago
over 15 years ago
Patents
The present invention relates to a process for the preparation of alicyclic acid dianhydride, more particularly relates to the preparation of 3 - methyl - 1, 2, 4 - pentamethylene three carboxylic acid - 1, 4:2, 3 – dianhydride.
Registered Trademarks
[Class : 1] Chemical Used In Industry, Science, Photography, Agriculture, Horticulture And Forestry
[Class : 42] Medicinal Research Services; Product Development Services
[Class : 5] Medicinal &Pharmaceutical Preparations
View +8 more Brands for Vivan Life Sciences Private Limited.
Charges
30 January 2018
Axis Bank Limited
3 Crore
03 March 2016
Standard Chartered Bank
1 Crore
25 March 2013
State Bank Of India
1 Crore
26 September 2012
Icici Bank Limited
1 Crore
29 April 2022
Deutsche Bank Ag
1 Crore
26 October 2023
Standard Chartered Bank
0
30 January 2018
Axis Bank Limited
0
29 April 2022
Others
0
26 September 2012
Icici Bank Limited
0
25 March 2013
State Bank Of India
0
03 March 2016
Standard Chartered Bank
0
26 October 2023
Standard Chartered Bank
0
30 January 2018
Axis Bank Limited
0
29 April 2022
Others
0
26 September 2012
Icici Bank Limited
0
25 March 2013
State Bank Of India
0
03 March 2016
Standard Chartered Bank
0
26 October 2023
Standard Chartered Bank
0
30 January 2018
Axis Bank Limited
0
29 April 2022
Others
0
26 September 2012
Icici Bank Limited
0
25 March 2013
State Bank Of India
0
03 March 2016
Standard Chartered Bank
0
Documents
Form MGT-14-27022020_signed
Form PAS-3-27022020_signed
Copy of the special resolution authorizing the issue of bonus shares;-27022020
Optional Attachment-(1)-27022020
Copy of Board or Shareholders? resolution-27022020
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-27022020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-27022020
Form AOC - 4 CFS-31122019-signed
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-09122019
Form AOC-4-09122019-signed
Form MGT-7-07122019_signed
List of share holders, debenture holders;-06122019
Statement of Subsidiaries as per section 129 - Form AOC-1-28112019
Directors report as per section 134(3)-28112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28112019
Form ADT-1-15102019_signed
Copy of written consent given by auditor-15102019
Copy of resolution passed by the company-15102019
Form DPT-3-03072019
Form MGT-7-29122018_signed
Form PAS-3-04032019_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-04032019
Copy of the special resolution authorizing the issue of bonus shares;-04032019
Copy of Board or Shareholders? resolution-04032019
Form MGT-14-26022019_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-26022019
Optional Attachment-(1)-26022019
Directors report as per section 134(3)-31122018
Form AOC-4-31122018_signed
